X-149483219-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000202.8(IDS):c.1181-1G>A variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000202.8 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IDS | NM_000202.8 | c.1181-1G>A | splice_acceptor_variant, intron_variant | Intron 8 of 8 | ENST00000340855.11 | NP_000193.1 | ||
IDS | NM_001166550.4 | c.911-1G>A | splice_acceptor_variant, intron_variant | Intron 8 of 8 | NP_001160022.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IDS | ENST00000340855.11 | c.1181-1G>A | splice_acceptor_variant, intron_variant | Intron 8 of 8 | 1 | NM_000202.8 | ENSP00000339801.6 | |||
ENSG00000241489 | ENST00000651111.1 | c.548-1G>A | splice_acceptor_variant, intron_variant | Intron 13 of 13 | ENSP00000498395.1 | |||||
ENSG00000241489 | ENST00000422081.6 | c.548-1G>A | splice_acceptor_variant, intron_variant | Intron 8 of 8 | 2 | ENSP00000477056.1 | ||||
ENSG00000241489 | ENST00000441880.1 | n.288-1G>A | splice_acceptor_variant, intron_variant | Intron 2 of 2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Mucopolysaccharidosis, MPS-II Pathogenic:3Other:1
Null variant (PVS1_Strong), Prevalence of the variant significantly increased in affected individuals compared with controls (PS4_Supporting), Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Patient’s phenotype or family history highly specific for the disease (PP4_Moderate) -
- -
For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that disruption of this splice site results in activation of a cryptic splice site and introduces a new termination codon (PMID: 7728156, 27883178). However the mRNA is not expected to undergo nonsense-mediated decay. ClinVar contains an entry for this variant (Variation ID: 221218). Disruption of this splice site has been observed in individual(s) with mucopolysaccharidosis type II (PMID: 7728156, 17063374, 27883178, 34813777, 35144014). This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 8 of the IDS gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely disrupts the C-terminus of the protein. -
The change c.1181-1G>A is a known splice donor variant. This mutation is due to substitution of G to A at nucleotide position c.1181-1G>A in the intron 8 of IDS gene. It was detected in a hemizygous state in one patient with attenuated phenotype from Delhi, India. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at